CardioLogs ECG Analysis Platform vs Eko Foundation Analysis Software with Transformers (EFAST)

EFAST offers real-time AI analysis directly during auscultation, seamlessly integrating with Eko digital stethoscopes to provide immediate actionable insights at the point of care. This direct enhancement of the live examination process, coupled with features like enhanced audio and guided exams, makes it highly intuitive for clinicians. While CardioLogs streamlines post-acquisition analysis, EFAST's real-time interaction during the physical exam provides a more immediate and integrated user experience.

CardioLogs demonstrates a broader validated clinical utility, aiding in the detection and diagnosis of over 20 types of arrhythmias, including AFib (97% sensitivity, 91% PPV) and VT (97% sensitivity). It has also received FDA clearance for pediatric use and has shown superior performance compared to consumer wearables like the Apple Watch ECG algorithm. While EFAST provides strong metrics for structural murmurs and AFib, CardioLogs' extensive range of detected arrhythmias and proven efficacy across diverse patient populations and devices gives it a slight edge.

EFAST provides more transparency regarding its pricing structure, offering a subscription-based Eko+ membership and a free trial with stethoscope purchase, along with an estimated daily cost for its advanced stethoscope technology [JSON]. Eko stethoscopes are also HSA/FSA eligible, which adds to its perceived value. CardioLogs, while offering a 'pay per ECG' model, requires contacting sales for a customized quote, providing less upfront detail [JSON].

Both tools are cloud-based, HIPAA compliant, FDA cleared, and offer EHR/EMR integration, making them suitable for enterprise environments [JSON, cite: 9, 22]. However, EFAST explicitly confirms the availability of a Business Associate Agreement (BAA) and provides detailed network connectivity guides, including firewall permissions and system requirements for enterprise customers [JSON, cite: 30]. While CardioLogs mentions ISO/IEC 27001 certified AWS servers, Eko's explicit BAA confirmation and comprehensive deployment resources offer a slightly more robust enterprise readiness profile.

While CardioLogs was a pioneer as the first FDA-cleared AI solution for ECG analysis in 2017 and leverages deep neural networks for multi-device compatibility [JSON, cite: 3, 14], EFAST introduces a more disruptive innovation by being the first FDA-cleared *foundation model* for cardiovascular AI. Its real-time AI analysis integrated directly into the auscultation workflow, transforming the physical exam at the point of care, represents a significant advancement in immediate clinical utility [JSON, cite: 5].

Eko Health offers a comprehensive Help Center with user manuals and FAQs, alongside multiple direct support channels including live Q&A sessions, 1:1 phone calls, and email support via a contact form. This proactive and accessible approach, coupled with educational resources and video tutorials, provides a slightly more robust and user-friendly support experience. CardioLogs, while backed by Philips' enterprise support, has less detailed public-facing information on its direct support channels.